Delivery of a hammerhead ribozyme specifically down-regulates the production of fibrillin-1 by cultured dermal fibroblasts

Human Molecular Genetics

Volumn 5, Issue 12, 1996, Pages 1939-1944

  Kilpatrick, Michael W ^a   Phylactou, Leonidas A ^a   Godfrey, Maurice ^b   Wu, Catherine H ^a   Wu, George Y ^a   Tsipouras, Petros ^a  

^a UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

^b UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ELASTIN; FIBRILLIN; GLYCOPROTEIN; MESSENGER RNA; POLYLYSINE; RIBOZYME; TRANSFERRIN;

ARTICLE; CATALYSIS; CONTROLLED STUDY; DNA FLANKING REGION; DOWN REGULATION; ENDOCYTOSIS; FIBER; FIBROBLAST CULTURE; GENE MUTATION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN SYNTHESIS; SKIN FIBROBLAST; TRANSACTIVATION;

EID: 0029804836     PISSN: 09646906     EISSN: None     Source Type: Journal    
DOI: 10.1093/hmg/5.12.1939     Document Type: Article

References (39)

1. Cech, T.R. and Bass, B.L. (1986) Biological catalysis by RNA. Annu. Rev. Biochem., 55, 599-629.
2. Haseloff, J and Gerlach, W (1988) Simple RNA enzymes with new and highly specific endoribonuclease activities. Nature, 334, 585-591.
3. Uhlenbeck, O.C. (1987) A small catalytic oligoribonucleotide. Nature, 328, 596-600.
4. Sarver, N., Cantin, E.M., Chang, P.S., Zaia, J.A., Ladne, P.A., Stephens, D.A. and Rossi, J.J. (1990) Ribozymes as potential anti-HIV-1 therapeutic agents. Science, 247, 1222-1225.
5. Scanlon, K.J., Jiao, L., Funato, T., Wang, W., Tone, T., Rossi, J.J. and Kashani-Sabet, M. (1991) Ribozyme-mediated cleavage of c-fos mRNA reduces gene expression of DNA synthesis enzymes and metallothionine. Proc. Natl Acad. Sci. USA, 88, 10591-10595.
6. Steinecke, P., Herget, T. and Schreier, P.H. (1992) Expression of a chimeric ribozyme gene results in endonucleolytic cleavage of target mRNA and a concomitant reduction at gene expression in vivo. EMBO J., 11, 1525-1530.
7. L'Hullier, P.J., Davis, S.R. and Bellamy, A.R. (1992) Cytoplasmic delivery of ribozymes leads to efficient reduction in α-lactalbumin mRNA levels in CI271 mouse cells. EMBO J., 11, 4411-4418.
8. Elli, J. and Rogers, J. (1993) Design and specificity of hammerhead ribozymes against calretinin mRNA. Nucleic Acids Res., 21, 5171-5178.
9. Sakai, L.Y., Keene, D.R. and Engvall, E. (1986) Fibrillin, a new 350-kD glycoprotein is a component of the extracellular microfibrils. J. Cell Biol., 103, 2499-2509.
10. Pereira, L., D'Alessio, M., Ramirez, F., Lynch, J.R., Sykes, B., Pangilinan, T. and Bonadio, J. (1993) Genomic organisation of the coding sequence for fibrillin, the defective gene product of Marfan syndrome. Hum. Mol. Genet., 2, 961-968.
11. Dietz, H.C., Cutting, G.R., Pyeritz, R.E., Maslen, C.L., Sakai, L.Y., Corson, G.M. Puffenberger, E.G., Hamosh, A., Nanthakumar, E.J., Currinstin, S.M., Stetten, G., Meyers, D.A. and Francomano, C.A. (1991) Marfan syndrome is caused by a recurrent de novo missense mutation in the fibrillin gene. Nature, 35, 337-339.
12. Dietz, H.C., Pyeritz, R.E., Puffenberger, G., Kendzior, R.J., Corson, G.M., Maslen, C.L., Sakai, L.Y., Francomano, C.A. and Cutting, G.R. (1992) Marfan phenotype variability in a family segregating a missense mutation in the epidermal growth factor-like motif of the fibrillin gene. J. Clin. Invest., 89, 1674-1680.
13. Dietz, H.C., Savaiva, J.M., Pyeritz, R.E., Cutting, G.R. and Francomano, C.A. (1992) Clustering of fibrillin (FBN1) mutations in Marfan syndrome patients at cysteine residues in EGF-like domains. Hum. Mutat., 1, 366-374.
14. Dietz, H.C., McIntosh, I., Sakai, L.Y. Corson, G.M., Calberg, S.M., Pyeritz, R.E. and Francomano, C.A. (1993) Four novel FBN1 mutations: significance for mutant transcript level and EGF-like domain calcium binding in the pathogenesis of Marfan syndrome. Genomics, 17, 468-475.
15. Dietz, H.C., Valle, D., Francomano, C.A., Kendzior, R.A., Jr, Pyeritz, R.E. and Cutting, G.R. (1993) The skipping of constitutive exons in vivo induced by nonsense mutations. Science, 259, 680-683.
16. Hewett, D.R., Lynch, J.R., Smith, R. and Sykes, B. (1993) A novel fibrillin mutation in the Marfan syndrome which could disrupt calcium binding of the epidermal growth factor-like module. Hum. Mol. Genet., 2, 475-477.
17. Godfrey, M., Vandemark, N., Wang, M., Velinov, M., Wagorski, D., Droste, S. and Rao, V.H. (1993) Prenatal diagnosis and a donor splice-site mutation in fibrillin in a family with Marfan syndrome. Am. J. Hum. Genet., 53, 472-480.
18. Kainulainen, K., Sakai, L.Y., Child, A., Pope, F.M., Puhakka, L., Ryhanen, L., Palotie, A., Kaitila, L. and Peltonen, L. (1992) Two mutations in Marfan syndrome resulting in truncated fibrillin polypeptides. Proc. Natl Acad. Sci. USA, 89, 5917-5921.
19. Kainulainen, K., Karrtunen, L., Puhakka, L., Sakai, L.Y. and Peltonen, L. (1994) Mutations in the fibrillin gene responsible for dominant ectopia lentis and neonatal Marfan syndrome. Nature Genet., 6, 64-69.
20. Piersall, L.D., Dietz, H.C., Hall, B.D., Cadle, R.G., Pyeritz, R.E., Francomano, C.A. and McIntosh, I. (1994) Substitution of a cysteine residue in a non-calcium binding, EGF-like domain of fibrillin segregates with the Marfan syndrome in a large kindred. Hum. Mol. Genet., 3, 1013-1014.
21. Tynan, K., Comeau, K., Pearson, M., Wilgenbus, P., Levin, D., Gasner, C., Berg, M.A., Miller, D.C. and Francke, U. (1993) Mutation screening of the complete fibrillin-1 coding sequence: report of five new mutations, including two in 8-cysteine domains. Hum. Mol. Genet., 3, 1813-1821.
22. Wang, M., Price, C.E., Han, J., Cisler, J., Imaizumi, K., Van Thienen, M.N., DePaepe, A. and Godfrey, M. (1995) Recurrent mis-splicing of fibrillin exon 32 in two patients with neonatal Marfan syndrome. Hum. Mol. Genet., 4, 607-613.
23. Nijbroek, D., Sood, S., McIntosh, I., Francomano, C., Bull, E., Periera, L., Ramirez, F., Pyeritz, R.E. and Dietz, H.C. (1995) Fifteen novel FBN1 mutations causing Marfan syndrome detected by heteroduplex analysis of genomic amplicons. Am. J. Hum. Genet., 57, 8-21.
24. Dietz, H.C. and Pyeritz, R.E. (1995) Mutations in the human gene for fibrillin-1 (FBN1) in the Marfan syndrome and related disorders. Hum. Mol. Genet., 4, 1799-1809.
25. Milewicz, D.M., Grossfield, J., Cao, S-N., Kielty, C., Covitz, W. and Jewett, T. (1995) A mutation in FBN1 disrupts profibrillin processing and results in isolated skeletal features of Marfan syndrome. J. Clin. Invest., 95, 2373-2378.
26. Karttunen, L., Raghunath, M., Lonnqvist, L. and Peltonen, L. (1994) A compound-heterozygous Marfan patient: two defective fibrillin alleles result in a lethal phenotype. Am. J. Hum. Genet., 55, 1083-1091.
27. Stahl-Hallengren, C., Ukkonen, T., Kainulainen, K., Kristofersson, U., Saxne, T., Tornqvist, K. and Peltonen, L. (1994) An extra cysteine in one of the non-calcium-binding epidermal growth factor-like motifs of the FBN1 polypeptide is connected to a novel variant of Marfan syndrome. J. Clin. Invest., 94, 709-713.
28. Gibson, M.A., Hughes, J.L., Fanning, J.C. and Cleary, E.G. (1986) The major antigen of elastin-associated microfibrils is a 31-kDa glycoprotein. J. Biol. Chem., 261, 11429-11436.
29. Pyeritz, R.E. and McKusick, V.A. (1979) The Marfan syndrome: diagnosis and management. N. Engl. J. Med., 300, 772-777.
30. Godfrey, M. (1993) The Marfan syndrome. In Beighton, P. (ed.), McKusick's Heritable Disorders of Connective Tissue. The C.V. Morby Company, St. Louis, MO, pp. 51-135.
31. Tsipouras, P and Kilpatrick, M.W. (1994) Marfan syndrome. In Jay, B. and Wright, A. (eds), Molecular Genetics of Inherited Eye Disorders. Harwood Academic Publishers, London, in press.
32. Pyeritz, R.E. (1990) Marfan syndrome. In Emery, A.E.H. and Rimoin, D.L. (eds), Principles and Practice of Medical Genetics. 2nd edn. Churchill-Livingstone, New York, pp. 1047-1063.
33. Aoyama, T., Francke, U., Dietz, H.C. and Furthmayr, H. (1994) Quantitative differences in biosynthesis and extracellular deposition of fibrillin in cultured fibroblasts distinguish five groups of Marfan syndrome patients and suggest distinct pathogenetic mechanisms. J. Clin. Invest., 94, 130-137.
34. Eldadah, Z., Brenn, T., Furthmayr, H. and Dietz, H.C. Expression of a mutant human fibrillin allele upon a normal human or murine genetic background recapitulates a Marfan cellular phenotype. J. Clin. Invest., 95, 874-880.
35. Zoumadakis, M., Neubert, W.J. and Tabler, M. (1994) The influence of imperfectly paired helices I and III on the catalytic activity of hammerhead ribozymes. Nucleic Acids Res., 24, 5271-5278.
36. Wagner, E., Zenke, M., Cotton, M., Beug, H. and Birnstiel, M.L. (1990) Transferrin-polycation conjugates as carriers for DNA uptake into cells. Proc. Natl Acad. Sci. USA, 87, 3410-3414.
37. Cotten, M., Wagner, E. and Birnstiel, M. (1993) Receptor-mediated transport of DNA into eukaryotic cells. Methods Enzymol., 217, 618-644.
38. Wu, G.Y. and Wu, C.H. (1988) Receptor-mediated gene delivery and expression in vivo. J. Biol. Chem., 263, 14621-14624.
39. Godfrey, M., Olson, S., Burgio, S.G., Martini, A., Valli, M., Cetta, G., Hori, H. and Hollister, D.W. (1990) Unilateral microfibrillar abnormalities in a case of asymmetric Marfan syndrome. Am. J. Hum. Genet., 46, 661-667.